483
Amanda L. Cox, MDAmanda L. Cox, MD – FDA 483, May 10, 2024
Record Details
An FDA inspection of Mount Sinai Kravis Children's Hospital identified a significant issue in a clinical investigation involving children. The principal investigator failed to consistently obtain permission from both parents for enrolled subjects, which is a requirement per institutional review board approval and for the COVID-19 addendum to informed consent forms. This indicates a critical lapse in ensuring proper informed consent for pediatric participants.
View Company Profile
ID · a2e7ceae-7ee5-40ea-8852-f6711bf43a70
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.